Off-label use of rituximab for systemic lupus erythematosus in Europe

Autor: Ryden-Aulin, Monica, Boumpas, Dimitrios, Bultink, Irene, Rubio, Jose Luis Callejas, Caminal-Montero, Luis, Castro, Antoni, Colodro Ruiz, Agustin, Doria, Andrea, Domer, Thomas, Gonzalez-Echavarri, Cristina, Gremese, Elisa, Houssiau, Frederic A., Huizinga, Tom, Inana, Murat, Isenberg, David, Luliano, Annamaria, Jacobsen, Soren, Jimenez-Alonso, Juan, Kovacs, Laszlo, Mariette, Xavier, Mosca, Marta, Nived, Ola, Oristrell, Joaquim, Ramos-Casals, Manuel, Rascon, Javier, Ruiz-Irastorza, Guillermo, Saez-Comet, Luis, Salvador Cervello, Gonzalo, Cervello, Gonzalo Salvador, Sebastiani, Gian Domenico, Squatrito, Danilo, Szucs, Gabriella, Voskuyl, Alexandre, van Vollenhoven, Ronald

Publikováno v: Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Lupus Science and Medicine, 3(1). BMJ Publishing Group
Ryden-Aulin, M, Boumpas, D T, Bultink, I, Rubio, J L C, Caminal-Montero, L, Castro, A, Ruiz, A C, Doria, A, Dorner, T, Gonzalez-Echavarri, C, Gremese, E, Houssiau, F A, Huizinga, T, Inanc, M, Isenberg, D, Iuliano, A, Jacobsen, S, Jimenez-Alonso, J, Kovács, L, Mariette, X, Mosca, M, Nived, O, Oristrell, J, Ramos-Casals, M, Rascon, J, Ruiz-Irastorza, G, Sáez-Comet, L, Cervello, G S, Sebastiani, G D, Squatrito, D, Szucs, G, Voskuyl, A E & van Vollenhoven, R F 2016, ' Off-label use of rituximab for systemic lupus erythematosus in Europe ', Lupus Science and Medicine, vol. 3, no. 1, 000163 . https://doi.org/10.1136/lupus-2016-000163
Rydén-Aulin, M, Boumpas, D, Bultink, I, Callejas Rubio, J L, Caminal-Montero, L, Castro, A, Colodro Ruiz, A, Doria, A, Dörner, T, Gonzalez-Echavarri, C, Gremese, E, Houssiau, F A, Huizinga, T, Inanç, M, Isenberg, D, Iuliano, A, Jacobsen, S, Jimenéz-Alonso, J, Kovács, L, Mariette, X, Mosca, M, Nived, O, Oristrell, J, Ramos-Casals, M, Rascón, J, Ruiz-Irastorza, G, Sáez-Comet, L, Salvador Cervelló, G, Sebastiani, G D, Squatrito, D, Szücs, G, Voskuyl, A & van Vollenhoven, RF 2016, ' Off-label use of rituximab for systemic lupus erythematosus in Europe ', Lupus Science and Medicine, vol. 3, no. 1, pp. e000163 . https://doi.org/10.1136/lupus-2016-000163
Lupus Science & Medicine
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona

OBJECTIVES: Rituximab (RTX) is a biological treatment used off-label in patients with systemic lupus erythematosus (SLE). This survey aimed to investigate the off-label use of RTX in Europe and compare the characteristics of patients receiving RTX wi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d11d5b6c4cbcb2275f5c5ad540fbb836
https://ddd.uab.cat/record/185989

Necrotizing Granulomatous Inflammation With Airway Tissue Destruction

Autor: Almenara Escribano, María Dolores, Colodro Ruiz, Agustín, Martín Armada, María

Publikováno v: In Archivos de Bronconeumología (English Edition) July 2018 54(7):389-389